Abstract
We have studied the influence of serological matching for ten HLA-DR antigens on the occurrence of acute cellular rejection in heart transplantation by correlating the findings in routine endomyocardial biopsies taken during the first posttransplant year with the results of HLA typing of all recipients of a first cardiac graft and their donors during 1983–1994 at our center. We found that recipients of HLA-DR matched hearts had a lower frequency of acute cellular rejection, especially so for the moderate/severe rejection grades. Also, rejection appeared earlier in the DR-mismatched combinations. Whether the mismatch was for one or two DR antigens did not make a significant difference, neither could we demonstrate any influence of HLA-A or -B mismatches. The survival of DR-matched cardiac grafts tended to be higher at 1 year than DR-mismatched grafts, but the difference did not reach statistical significance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group. J Heart Transplant 9: 587–593
DeMattos A, Head MA, Everett J, Hosenpud J, Hershberger R, Conaglu A, Ott G, Ratkovec R, Norman DJ (1994) HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high confidence-level serological DR typing is used. Transplantation 57: 626–630
DiSesa VJ, Kuo PC, Horvath KA, Mudge GH, Collins JJ, Cohn LH (1990) HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation. Ann Thorac Surg 49: 220–224
Foerster A, Abdelnoor M, Geiran O, Lindberg H, Simonsen S, Thorsby E, Frt ysaker T (1992) Morbidity risk factors in human cardiac transplantation. Histoincompatibility and protracted graft ischemia entail high risk of rejection and infection. Scand J Thorac Cardiovasc Surg 26: 169–176
Leivestad T, Spurkland A, Bratlie A, Pfeffer P, Fauchald P, Social G, Thorsby E (1994) Does genomic HLA-DR matching further enhance the effects of serologic DR matching in clinical renal transplantation? Transplant Proc 26: 1748–1749
Morris PJ (Ed) (1994) HLA matching and cardiac transplantation. N Engl J Med 330: 857–858
Opelz G, Wujciak T (1994) The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med 330: 816–819
Pfeffer PF, Foerster A, Frt ysaker T, Simonsen S, Thorsby E (1988) HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated. Transplant Proc 20: 367–368
Sheldon S, Hasleton PS, Yonan NA, Rhaman AN, Deiraniya AK, Campbell CS, Brooks NH, Dyer PA (1994) Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplantation 58: 719–722
Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, Thorsby E (1986) HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation — a fast and reliable technique. Tissue Antigens 28: 301–312
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Leivestad, T., Foerster, A., Simonsen, S., Bratlie, A., Thorsby, E., Geiran, O. (1996). HLA-DR matching reduces rejection rate in heart transplantation. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_59
Download citation
DOI: https://doi.org/10.1007/978-3-662-00818-8_59
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61024-3
Online ISBN: 978-3-662-00818-8
eBook Packages: Springer Book Archive